LAST CAPITAL SEEK ROUND CLOSED 16/02/2024 WITH +3M€. STAY TUNED!

We aim to finance Phase III clinical trials for brain tumor treatment. 

For more information about this investment opportunity click here

email inversores@laminarpharma.com.

The latest LAMINAR PHARMA WEBINAR held on DECEMBER 12, 2023 is NOW AVAILABLE